article_metadata: Idris Boudhabhay Marion Rabant Lubka T Roumenina Louis-Marie Coupry Victoria Poillerat Armance Marchal Véronique Frémeaux-Bacchi Khalil El Karoui Mehran Monchi Franck Pourcine
article_metadata: 10.3389/fimmu.2021.680567
article_metadata: Front Immunol
article_metadata: 2021 Jun 23;12:680567.
article_metadata: covid-19 case report complement system eculizumab multisystem inflammatory syndrome thrombotic microangiopathy
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34248962/
article_metadata: Antibodies, Monoclonal, Humanized / therapeutic use COVID-19 / diagnosis Complement Inactivating Agents / therapeutic use Kidney / metabolism SARS-CoV-2 / physiology Systemic Inflammatory Response Syndrome / diagnosis Thrombotic Microangiopathies / diagnosis
article_metadata: Antibodies, Monoclonal, Humanized / therapeutic use COVID-19 / diagnosis Complement Inactivating Agents / therapeutic use Kidney / metabolism SARS-CoV-2 / physiology Systemic Inflammatory Response Syndrome / diagnosis Thrombotic Microangiopathies / diagnosis Case Reports COVID-19 Drug Treatment Humans Kidney / pathology Male Middle Aged Pandemics Recovery of Function Systemic Inflammatory Response Syndrome / drug therapy Thrombotic Microangiopathies / drug therapy Antibodies, Monoclonal, Humanized Complement Inactivating Agents adult multisystem inflammatory disease, COVID-19 related eculizumab
article_metadata: PMC8260674
article_metadata: 34248962
article_metadata: Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy
article_metadata: 2021